about
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...
Read More
15.16
-0.45
(-2.88%)
71,016
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Korro Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..